Systemic lupus erythematosus
Not recruitingEvaluation of safety and efficacy of 19CP02 combined with cyclophosphamide and fludarabine phosphate in adults with treatment‑refractory active systemic lupus erythematosus
Evaluation of safety and efficacy of 19CP02 combined with cyclophosphamide and fludarabine phosphate in adults with treatment‑refractory active systemic lupus erythematosus
- Disease:Systemic lupus erythematosus
- Substances:Cyclophosphamide19Cp02+1
Belgium- Participants:18–64 years
- Substances:Cyclophosphamide












